This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Gastroenteropancreatic Neuroendocrine Tumor

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Gastroenteropancreatic Neuroendocrine Tumor Means

Gastroenteropancreatic neuroendocrine tumors, often called GEP-NETs, are uncommon growths that develop from hormone-producing cells in the pancreas or the gastrointestinal tract. These areas include the stomach, small intestine, colon, rectum, and appendix. The cells involved normally release hormones that help regulate body functions. Sometimes, these tumors produce extra hormones, which can cause symptoms.

GEP-NETs can be either benign (non-cancerous) or malignant (cancerous). They are sometimes called carcinoid tumors or islet cell tumors, depending on their location and behavior. Because they arise from hormone-secreting cells, they may affect the body differently than other types of tumors.

Why GEP-NETs Matter in Cancer Care

Although rare, GEP-NETs are important because they can cause symptoms related to hormone overproduction, such as flushing, diarrhea, or a condition called carcinoid syndrome. Their behavior varies widely—from slow-growing tumors that may not spread, to more aggressive cancers. Treatment depends on the tumor’s type, location, hormone activity, and whether it has spread.

Some medications used to treat GEP-NETs work by mimicking natural hormones like somatostatin, which can help control hormone-related symptoms and slow tumor growth. For example, lanreotide acetate is a drug that helps reduce excess hormone production. Another treatment, Lutathera (lutetium Lu 177-dotatate), is a radioactive drug that targets tumor cells with somatostatin receptors, delivering radiation directly to them.

What Patients Might See or Hear About GEP-NETs

When this term appears in medical reports, it may be alongside other names like carcinoid tumor or islet cell tumor. Patients might hear about hormone-related symptoms or tests that check for hormone levels. Doctors may discuss imaging scans, biopsies, or treatments tailored to the tumor’s characteristics.

Because GEP-NETs can produce extra hormones, patients might experience symptoms that seem unrelated to cancer, such as skin flushing or digestive issues. Understanding these symptoms and their connection to the tumor can help patients and caregivers communicate effectively with their care team.

Where the Term May Appear

The term GEP-NET can show up in pathology reports, imaging results, treatment plans, or clinical trial descriptions. It may also be mentioned when discussing medications like lanreotide acetate or Lutathera, which are used specifically for certain types of these tumors. Seeing the term in different contexts highlights the importance of asking your care team what it means for your individual case.

What GEP-NET Does Not Automatically Mean

Seeing the term GEP-NET does not by itself tell you whether the tumor is cancerous or how aggressive it might be. It also does not specify the exact symptoms or treatment needed. Each person’s situation is unique, so the term should not be used alone to make decisions or assumptions about prognosis or therapy.

Common Questions to Ask Your Care Team

Patients and caregivers might ask: Is the tumor benign or malignant? What symptoms might be caused by hormone production? What treatments are available, and how do they work? Are there specific tests to understand the tumor better? How will this diagnosis affect my daily life and follow-up care?

How to Read the Term in Context

Because GEP-NET can refer to a range of tumors with different behaviors and treatments, it’s important to consider the full medical report or discussion. Look for details about tumor grade, hormone activity, and treatment options. Always ask your care team to explain what the term means for your health and care plan.

Safety and Next Steps

This information is meant to help you understand the term gastroenteropancreatic neuroendocrine tumor but does not replace medical advice. If you see this term in your medical records or hear it from your care team, the best next step is to ask them directly how it applies to your situation. They can provide personalized explanations and guide you through diagnosis, treatment, and follow-up.

Sources

Public source information used for this glossary entry includes: